Trial · NCT07912970
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Functional Independence at 90 Days | Day 90 ± 7 days after randomization | Proportion of participants with functional independence at 90 days after randomization, defined as a modified Rankin Scale score of 0 to 2. The modified Rankin Scale ranges from 0 to 6, with lower scores indicating less disability. |
| Secondary | Distribution of Modified Rankin Scale Scores at 90 Days | Day 90 ± 7 days after randomization | Distribution of modified Rankin Scale scores at 90 days after randomization. The modified Rankin Scale ranges from 0 to 6, with higher scores indicating greater disability. |
| Secondary | Excellent Functional Outcome at 90 Days | Day 90 ± 7 days after randomization | Proportion of participants with a modified Rankin Scale score of 0 to 1 at 90 days after randomization. |
| Secondary | Favorable Functional Outcome at 90 Days | Day 90 ± 7 days after randomization | Proportion of participants with a modified Rankin Scale score of 0 to 3 at 90 days after randomization. |
| Secondary | Early Recanalization of the Target Vessel at the Receiving Stroke Center | Within 24 hours after randomization (at the first vascular imaging assessment upon arrival at the receiving stroke center). | Proportion of participants with recanalization of the initially occluded target vessel on the first vascular imaging assessment at the receiving stroke center, assessed by CTA, MRA, or the first DSA. |
| Secondary | Successful Recanalization of the Target Vessel Within 48 Hours | Within 48 hours after randomization | Proportion of participants with recanalization of the initially occluded target vessel on CTA or MRA within 48 hours after randomization. |
| Secondary | Early Neurological Improvement | 72 ± 12 hours after randomization | Proportion of participants with a decrease in the National Institutes of Health Stroke Scale (NIHSS) score of at least 8 points from baseline, or an NIHSS score of 0 to 1, at the 72-hour assessment. |
| Secondary | EQ-5D-5L Score at 90 Days | Day 90 ± 7 days after randomization | EQ-5D-5L assessment at 90 days after randomization, performed by an assessor blinded to treatment allocation. |
| Secondary | Barthel Index at 90 Days | Day 90 ± 7 days after randomization | Barthel Index score at 90 days after randomization, assessed by an assessor blinded to treatment allocation. Scores range from 0 to 100, with higher scores indicating greater independence in activities of daily living. |
| Other | Symptomatic Intracranial Hemorrhage Within 48 Hours | Within 48 hours after randomization | Proportion of participants with symptomatic intracranial hemorrhage within 48 hours after randomization, adjudicated according to the Heidelberg Bleeding Classification. |
| Other | All-Cause Mortality Within 90 Days | From randomization through day 90 | Proportion of participants who die from any cause within 90 days after randomization. |
| Other | Any Intracranial Hemorrhage Within 48 Hours | Within 48 hours after randomization | Proportion of participants with any intracranial hemorrhage detected on brain imaging within 48 hours after randomization, classified according to the Heidelberg Bleeding Classification. |
| Other | Serious Adverse Events Within 90 Days | From randomization through day 90 | Proportion of participants who experience at least one serious adverse event within 90 days after randomization. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07912970/registered